Trade Winds Shift for Pharma: Understanding the Section 232 Tariff Proclamation on Pharmaceuticals

Preparing for Pharmaceutical Tariffs: What Industry Can Do To Mitigate Supply Chain Risks

U.S. launches tariff probe into Germany's pharmaceutical pricing policies

U.S. Trade Representative Jamieson Greer said Germany's proposal to reduce spending on medicines was "a serious step backwards."

Tariff Pass-Through to Consumer Prices Is Far From Complete, Research Shows

A look at whether businesses have finished adjusting prices due to changes in U.S. trade policy or if further tariff-induced price increases

Tariff Pass-Through to Consumer Prices Is Far From Complete, Research Shows

A look at whether businesses have finished adjusting prices due to changes in U.S. trade policy or if further tariff-induced price increases

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade

Analysis: UK-US pharmaceuticals trade deal could divert NHS funds and harm public health

Samuel Cross, Karl Claxton, and Andrew Hill argue that diversion of billions of NHS funding to pay more for new drugs under the UK-US trade

Analysis: The Confusing Persistence of Trump's Tariff Strategy

The zombie trade war that just won't die

A Country‑Specific View of Tariffs

U.S. trade policy remains in flux. Nevertheless, important elements of the new policy regime are apparent in data through July. What stands